Synopsys, Inc. $SNPS Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in Synopsys, Inc. (NASDAQ:SNPS) by 107.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 282,116 shares of the semiconductor company’s stock after purchasing an additional 146,437 shares during the quarter. SG Americas Securities LLC’s holdings in Synopsys were worth $111,853,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Empirical Asset Management LLC acquired a new position in shares of Synopsys during the third quarter worth about $773,000. China Universal Asset Management Co. Ltd. lifted its position in Synopsys by 31.8% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after purchasing an additional 3,575 shares during the period. SeaTown Holdings Pte. Ltd. boosted its holdings in Synopsys by 55.9% in the 4th quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock valued at $10,475,000 after purchasing an additional 8,000 shares in the last quarter. Norges Bank purchased a new stake in Synopsys in the 4th quarter valued at approximately $730,197,000. Finally, Douglas Lane & Associates LLC increased its position in Synopsys by 5,701.2% during the 4th quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock worth $22,889,000 after purchasing an additional 47,890 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SNPS. Berenberg Bank set a $633.00 target price on Synopsys in a research note on Wednesday, May 27th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a “buy” rating in a research note on Wednesday, February 25th. Piper Sandler increased their price objective on Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. BNP Paribas Exane raised their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Finally, Morgan Stanley boosted their target price on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $563.81.

Insider Buying and Selling at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

SNPS opened at $455.51 on Monday. The stock has a market cap of $87.22 billion, a P/E ratio of 105.44, a P/E/G ratio of 2.68 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock’s 50 day simple moving average is $479.14 and its 200 day simple moving average is $462.21. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the firm posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.